SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $4,000 | -20.0% | 15,375 | 0.0% | 0.00% | – |
Q4 2015 | $5,000 | -81.5% | 15,375 | 0.0% | 0.00% | – |
Q3 2015 | $27,000 | -50.9% | 15,375 | -38.0% | 0.00% | – |
Q2 2015 | $55,000 | +52.8% | 24,785 | +32.7% | 0.00% | – |
Q1 2015 | $36,000 | -28.0% | 18,681 | -1.2% | 0.00% | – |
Q4 2014 | $50,000 | -54.1% | 18,906 | -13.6% | 0.00% | – |
Q2 2013 | $109,000 | – | 21,871 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 37,069,140 | $64,500,000 | 87.00% |
ARMISTICE CAPITAL, LLC | 2,000,000 | $3,480,000 | 1.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 432,259 | $752,000 | 0.28% |
Geller Advisors LLC | 187,323 | $326,000 | 0.21% |
CAXTON CORP | 57,000 | $99,000 | 0.13% |
Verity Asset Management, Inc. | 64,476 | $112,000 | 0.11% |
TFS CAPITAL LLC | 367,364 | $639,000 | 0.06% |
Cutler Capital Management, LLC | 72,500 | $126,000 | 0.06% |
LUCAS CAPITAL MANAGEMENT | 21,100 | $37,000 | 0.02% |
Nine Chapters Capital Management LLC | 129,700 | $226,000 | 0.02% |